ARCH Venture Management as of Sept. 30, 2024
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 45.5 | $118M | 4.8M | 24.50 | |
| Rapport Therapeutics (RAPP) | 29.3 | $76M | 3.7M | 20.48 | |
| Erasca (ERAS) | 11.6 | $30M | 11M | 2.73 | |
| Q32 Bio (QTTB) | 5.5 | $14M | 321k | 44.62 | |
| Verve Therapeutics (VERV) | 3.7 | $9.7M | 2.0M | 4.84 | |
| Gossamer Bio (GOSS) | 3.0 | $7.9M | 8.1M | 0.99 | |
| Singular Genomics Systems Com New | 0.8 | $2.0M | 127k | 15.67 | |
| Unity Biotechnology Com New | 0.6 | $1.5M | 1.0M | 1.47 | |
| Cero Therapeutics Holdings Class A Com | 0.1 | $135k | 1.4M | 0.09 |
